Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by MustangSalleyon Apr 29, 2022 4:21pm
131 Views
Post# 34643638

RE:Sernova communication.

RE:Sernova communication.
Ekenbullets wrote:

I found the comments around publicity a bit disturbing. Phil said something like we have gotten comments that others are getting publicity for having (one) successful patient but not Sernova. He then said something like we will try to also get publicity. 


First it seems like Sernova lack a clear plan on communication, to whom do we want to communicate and more importantly why. Phils comments indicate that it was not a strategi decision to not get general publicity. They now awake and will try to do what others already have done. Well I hate to tell you but being first on something is what gives you general publicity, hardly anyone writes about the second one (at least general media). So if Sernova acutually wanted this publicity (indicated by Phils comments)why have they not done PR work earlier when they could have been first? I suggested like a year ago to let the first patient speak out in media, lifechanging stuff is powerful media. Well what happened was that others did exactly that and that news went viral globally. Should have been Sernova. Amateurs. Then NOW trying to achieve that when its way too late is Amateurs x2. 


All and all very badly handled and still being handled badly. Are we actually paying some professionals for this?! If so cut them loose immediatly.



I totally agree with you Eken. Now getting another pr firm? Paying Ray Matthews, Chris , Life Sciences over $35 k US a month . No recognition by anybody . All they talk about is Vertex and Viacycte.  Sva has another insulin independent patient (3 rd) and crickets . What's wrong with this picture?

Why are they paying Ray Matthews for again?


MS
 

<< Previous
Bullboard Posts
Next >>